Gastroesophageal variceal hemorrhage in patients with chronic liver diseases attending university of Gondar Specialized comprehensive hospital in Ethiopia: Institutional based cross-sectional study.
Associated factors
Cirrhosis
Ethiopia
Variceal bleeding
Variceal hemorrhage
Journal
Heliyon
ISSN: 2405-8440
Titre abrégé: Heliyon
Pays: England
ID NLM: 101672560
Informations de publication
Date de publication:
Apr 2023
Apr 2023
Historique:
received:
21
04
2022
revised:
16
03
2023
accepted:
27
03
2023
medline:
25
4
2023
pubmed:
25
4
2023
entrez:
25
04
2023
Statut:
epublish
Résumé
Rupture and bleeding from Gastroesophageal Varices (GEVs) are major complications among patients with chronic liver disease (CLD) and are associated with a high mortality rate. Hence, identifying factors of Gastroesophageal Variceal Hemorrhage (GEVH) is essential for the management and prevention of this fatal outcome. To assess the prevalence of GEVH and its associated factors among patients with CLD in Northwest Ethiopia. An institutional based cross-sectional study design was employed on a total of 262 patients. The data was entered into Epi-Data version 3.1, and then exported and analyzed using STATA version 14. The distribution of variables was checked using kolmogorov-smirnov test. Bivariable logistic regression model was fitted to select variables for multivariable analysis. In the final model, adjusted odds ratio with 95% confidence level and P-value less than 0.05 were used to assess degree of association. The mean age of the study subjects was found to be 37.76 years (SD ± 11.62). The prevalence of GEVH was found to be 52% (95% CI: 49.6-54.2). Patients with grade F2 and F3 varices have 3.41 times (AOR: 3.41, 95% CI: 2.33-4.74) and 3.33 times (AOR: 3.33, 95% CI: 2.55-4.12) higher odds of bleeding, respectively. Patients not taking beta blocker have 2.38 times (AOR: 2.38, 95% CI: 1.82-3.90) increased odds of bleeding. Patients with more than three years of duration of illness have 2 times (AOR: 2.19, 95% CI: 1.39-3.99) increased odds of bleeding. Patients with platelet number less than 50,000/μl have 3.46 times (AOR: 3.46, 95% CI: 2.55-4.17) higher odds of bleeding. GEVH is found to be high in patients with CLD seen at university of Gondar Hospital. Higher grade of varices, non-use of beta blockers, presence of infection, platelet number and age are associated with higher occurrence of bleeding, pointing the possibility of averting this fatal complication, for most of the identified factors are preventable.
Identifiants
pubmed: 37095908
doi: 10.1016/j.heliyon.2023.e15133
pii: S2405-8440(23)02340-X
pmc: PMC10121785
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e15133Informations de copyright
© 2023 The Authors.
Déclaration de conflit d'intérêts
The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Denekew Tenaw Anley reports administrative support was provided by 10.13039/501100007861University of Gondar College of Medicine and Health Sciences.
Références
Hepatogastroenterology. 1999 Jan-Feb;46(25):391-4
pubmed: 10228828
Singapore Med J. 2008 Mar;49(3):239-42
pubmed: 18363007
J Gastroenterol Hepatol. 2004 Sep;19(9):1042-51
pubmed: 15304123
Am J Gastroenterol. 2016 Dec;111(12):1778-1787
pubmed: 27670600
J Clin Gastroenterol. 2007 Nov-Dec;41 Suppl 3:S300-4
pubmed: 17975480
Gastroenterology. 2002 May;122(6):1620-30
pubmed: 12016427
Arq Gastroenterol. 2019 Sep 30;56(3):286-293
pubmed: 31633727
Hepatology. 2007 Sep;46(3):922-38
pubmed: 17879356
J Clin Diagn Res. 2017 Sep;11(9):OC25-OC28
pubmed: 29207755
J Clin Gastroenterol. 2007 Nov-Dec;41 Suppl 3:S305-11
pubmed: 17975481
Endoscopy. 1986 May;18 Suppl 2:6-10
pubmed: 3519197
Am J Gastroenterol. 1995 Jun;90(6):959-61
pubmed: 7771430
Int J Tuberc Lung Dis. 2019 Mar 1;23(3):331-336
pubmed: 30871664
J Nippon Med Sch. 2013;80(4):252-9
pubmed: 23995567
Hepatol Int. 2018 Feb;12(Suppl 1):68-80
pubmed: 29210030
Clin Liver Dis. 2010 May;14(2):195-208
pubmed: 20682229
Gastroenterology. 1981 Apr;80(4):800-9
pubmed: 6970703
Eur J Med Res. 1996 Jun 25;1(9):407-16
pubmed: 9353240
Semin Liver Dis. 2008 Feb;28(1):3-25
pubmed: 18293274
Dig Dis Sci. 2009 May;54(5):1128-34
pubmed: 19051032
Cochrane Database Syst Rev. 2017 Apr 26;4:CD008759
pubmed: 28444987
J Hepatol. 2018 Jul;69(1):154-181
pubmed: 29628280
Gastroenterology. 1982 May;82(5 Pt 1):968-73
pubmed: 7037525
Emerg Infect Dis. 2019 Mar;25(3):441-450
pubmed: 30789141
Br J Surg. 1991 Oct;78(10):1252-3
pubmed: 1958998
Clin Microbiol Infect. 2018 Apr;24(4):381-388
pubmed: 28712668
Gastroenterol Rep (Oxf). 2016 Aug;4(3):186-95
pubmed: 27324725
N Engl J Med. 1988 Oct 13;319(15):983-9
pubmed: 3262200
Saudi J Gastroenterol. 2015 Jan-Feb;21(1):43-6
pubmed: 25672238
Hepatology. 1998 May;27(5):1207-12
pubmed: 9581672
Arq Gastroenterol. 2008 Jan-Mar;45(1):11-6
pubmed: 18425222
Best Pract Res Clin Gastroenterol. 2013 Oct;27(5):649-64
pubmed: 24160925